Cargando…
Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries
OBJECTIVES: Seven years after the introduction of direct-acting antivirals (DAAs) for the treatment of hepatitis C, high prices remain a barrier for treatment programs worldwide. This study seeks to describe current prices for originator DAAs in 50 countries and evaluate the relationship between pri...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646676/ https://www.ncbi.nlm.nih.gov/pubmed/33251019 http://dx.doi.org/10.1016/j.jve.2020.06.001 |